TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 6 filers reported holding TRINITY BIOTECH INVT LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 48,000,000 | $40,401,000 | 1.66% |
| Wellesley Asset Management | 29,650 | $25,332,000 | 1.31% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 23,875,000 | $20,234,000 | 0.36% |
| LINDEN ADVISORS LP | 8,590,000 | $7,321,000 | 0.29% |
| PALISADE CAPITAL MANAGEMENT, LP | 850,000 | $722,000 | 0.03% |
| Citadel Advisors | 4,000,000 | $3,391,000 | 0.00% |